Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,980 | 46,405 | 47,674 | N/A | N/A |
| Marketable Securities | 128,646 | 115,251 | 75,493 | N/A | N/A |
| TOTAL | $175,677 | $165,585 | $125,493 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 3,172 | 1,936 | 1,638 | N/A | N/A |
| Investments And Advances | 11,121 | 30,048 | 0 | 0 | 0 |
| Other Non-Current Assets | 290 | 290 | 2,302 | 0 | 0 |
| TOTAL | $14,583 | $32,274 | $3,940 | $N/A | $N/A |
| Total Assets | $190,260 | $197,859 | $129,433 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,044 | 2,830 | 2,663 | 0 | 0 |
| Accrued Expenses | 3,116 | 2,527 | 2,802 | N/A | N/A |
| TOTAL | $7,160 | $5,357 | $5,465 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 464 | 455 | 434 | 0 | 0 |
| TOTAL | $464 | $455 | $434 | $N/A | $N/A |
| Total Liabilities | $7,624 | $5,812 | $5,899 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,965 | 23,940 | N/A | N/A | N/A |
| Common Shares | 2 | 2 | N/A | N/A | N/A |
| Retained earnings | -155,958 | -144,895 | -85,590 | N/A | N/A |
| Other shareholders' equity | 212 | 1 | 209,124 | 0 | 0 |
| TOTAL | $182,636 | $192,047 | $123,534 | $N/A | $N/A |
| Total Liabilities And Equity | $190,260 | $197,859 | $129,433 | $0 | $0 |